Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.
Identifieur interne : 001B55 ( Main/Corpus ); précédent : 001B54; suivant : 001B56Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.
Auteurs : B. Allenet ; C. Chen ; T. Romanet ; P. Vialtel ; J. CalopSource :
- Pharmacy world & science : PWS [ 0928-1231 ] ; 2007.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Ambulatory Care (MeSH), Anemia (etiology), Anemia (therapy), Erythropoietin (therapeutic use), Female (MeSH), Follow-Up Studies (MeSH), France (MeSH), Health Knowledge, Attitudes, Practice (MeSH), Hemoglobins (drug effects), Hospitals, Teaching (MeSH), Humans (MeSH), Injections (instrumentation), Male (MeSH), Middle Aged (MeSH), Patient Compliance (psychology), Patient Education as Topic (MeSH), Pharmacists (MeSH), Pharmacy Service, Hospital (organization & administration), Professional Role (MeSH), Prospective Studies (MeSH), Quality of Life (MeSH), Recombinant Proteins (MeSH), Renal Insufficiency, Chronic (complications), Self Administration (methods).
- MESH :
- chemical , drug effects : Hemoglobins.
- chemical , therapeutic use : Erythropoietin.
- geographic : France, Recombinant Proteins.
- complications : Renal Insufficiency, Chronic.
- etiology : Anemia.
- instrumentation : Injections.
- methods : Self Administration.
- organization & administration : Pharmacy Service, Hospital.
- psychology : Patient Compliance.
- therapy : Anemia.
- Adult, Aged, Ambulatory Care, Female, Follow-Up Studies, Health Knowledge, Attitudes, Practice, Hospitals, Teaching, Humans, Male, Middle Aged, Patient Education as Topic, Pharmacists, Professional Role, Prospective Studies, Quality of Life.
Abstract
OBJECTIVE
Assessment of a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.
SETTING
Nephrology Department, Grenoble Hospital, France.
METHOD
A 12-week prospective study, using a before-after intervention design. Included in the study were predialysis outpatients with a haemoglobin level < 10 g/dl, de novo EPO prescription; judged qualified by the nephrologist for self-injections; accepting self-injections. The intervention was a single one-hour individual session between the pharmacist and the patient to target (1) medical and therapeutic information; (2) information on the device, a pen used with a cartridge of beta epoietin; (3) training with the pen; and (4) self-injection of the first dose by the patient, in front of the pharmacist. Main outcome measures were knowledge (7-item questionnaire); handling skills (observation) and Quality of Life (1 Likert scale on apprehension towards self-injections and 3 Linear Analog Scales on energy, daily activities, and general well-being); compliance (self-report on self-administered injections) and haemoglobin level.
RESULTS
Ten patients were followed for 3 months after intervention. The evolution of the knowledge was positive but not statistically significant after the programme (80% of good answers before; 93% 3 months later). Concerning the patients' skills, difficulties with the pen were important at inclusion, (1) to reset the pen into zero position (2.8 tries/patient +/- 1.8); (2) to insert a new cartridge (1.9 +/- 1.1); and (3) to take air out of the cartridge (2.3 +/- 1.2). After the session, results were satisfactory, since 3 months later, all patients were still on self-injections. QoL improved significantly over the study period respectively on energy, daily activities, and general well-being. The mean level of compliance remained above 90% at 3 months for 8 out of 10 patients. Patients reached the haemoglobin target value of 11 g/dl during the second month of treatment.
CONCLUSION
A tailored educational programme conducted by a pharmacist is beneficial for anaemia patients with chronic renal insufficiency. The programme seems to result in a high level of compliance, leading to an optimal haemoglobin level within two months.
DOI: 10.1007/s11096-005-4800-4
PubMed: 17268940
Links to Exploration step
pubmed:17268940Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.</title><author><name sortKey="Allenet, B" sort="Allenet, B" uniqKey="Allenet B" first="B" last="Allenet">B. Allenet</name><affiliation><nlm:affiliation>Département de Pharmacie, Pavillon Moidieu, CHU de Grenoble, BP 217, 38043 Grenoblex 9, France. BAllenet@chu-grenoble.fr</nlm:affiliation></affiliation></author><author><name sortKey="Chen, C" sort="Chen, C" uniqKey="Chen C" first="C" last="Chen">C. Chen</name></author><author><name sortKey="Romanet, T" sort="Romanet, T" uniqKey="Romanet T" first="T" last="Romanet">T. Romanet</name></author><author><name sortKey="Vialtel, P" sort="Vialtel, P" uniqKey="Vialtel P" first="P" last="Vialtel">P. Vialtel</name></author><author><name sortKey="Calop, J" sort="Calop, J" uniqKey="Calop J" first="J" last="Calop">J. Calop</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17268940</idno><idno type="pmid">17268940</idno><idno type="doi">10.1007/s11096-005-4800-4</idno><idno type="wicri:Area/Main/Corpus">001B55</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001B55</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.</title><author><name sortKey="Allenet, B" sort="Allenet, B" uniqKey="Allenet B" first="B" last="Allenet">B. Allenet</name><affiliation><nlm:affiliation>Département de Pharmacie, Pavillon Moidieu, CHU de Grenoble, BP 217, 38043 Grenoblex 9, France. BAllenet@chu-grenoble.fr</nlm:affiliation></affiliation></author><author><name sortKey="Chen, C" sort="Chen, C" uniqKey="Chen C" first="C" last="Chen">C. Chen</name></author><author><name sortKey="Romanet, T" sort="Romanet, T" uniqKey="Romanet T" first="T" last="Romanet">T. Romanet</name></author><author><name sortKey="Vialtel, P" sort="Vialtel, P" uniqKey="Vialtel P" first="P" last="Vialtel">P. Vialtel</name></author><author><name sortKey="Calop, J" sort="Calop, J" uniqKey="Calop J" first="J" last="Calop">J. Calop</name></author></analytic><series><title level="j">Pharmacy world & science : PWS</title><idno type="ISSN">0928-1231</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Ambulatory Care (MeSH)</term><term>Anemia (etiology)</term><term>Anemia (therapy)</term><term>Erythropoietin (therapeutic use)</term><term>Female (MeSH)</term><term>Follow-Up Studies (MeSH)</term><term>France (MeSH)</term><term>Health Knowledge, Attitudes, Practice (MeSH)</term><term>Hemoglobins (drug effects)</term><term>Hospitals, Teaching (MeSH)</term><term>Humans (MeSH)</term><term>Injections (instrumentation)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Patient Compliance (psychology)</term><term>Patient Education as Topic (MeSH)</term><term>Pharmacists (MeSH)</term><term>Pharmacy Service, Hospital (organization & administration)</term><term>Professional Role (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Quality of Life (MeSH)</term><term>Recombinant Proteins (MeSH)</term><term>Renal Insufficiency, Chronic (complications)</term><term>Self Administration (methods)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Hemoglobins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Erythropoietin</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term><term>Recombinant Proteins</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Renal Insufficiency, Chronic</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Anemia</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Injections</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Self Administration</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Pharmacy Service, Hospital</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Patient Compliance</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Anemia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Ambulatory Care</term><term>Female</term><term>Follow-Up Studies</term><term>Health Knowledge, Attitudes, Practice</term><term>Hospitals, Teaching</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Patient Education as Topic</term><term>Pharmacists</term><term>Professional Role</term><term>Prospective Studies</term><term>Quality of Life</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>Assessment of a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.</p></div><div type="abstract" xml:lang="en"><p><b>SETTING</b></p><p>Nephrology Department, Grenoble Hospital, France.</p></div><div type="abstract" xml:lang="en"><p><b>METHOD</b></p><p>A 12-week prospective study, using a before-after intervention design. Included in the study were predialysis outpatients with a haemoglobin level < 10 g/dl, de novo EPO prescription; judged qualified by the nephrologist for self-injections; accepting self-injections. The intervention was a single one-hour individual session between the pharmacist and the patient to target (1) medical and therapeutic information; (2) information on the device, a pen used with a cartridge of beta epoietin; (3) training with the pen; and (4) self-injection of the first dose by the patient, in front of the pharmacist. Main outcome measures were knowledge (7-item questionnaire); handling skills (observation) and Quality of Life (1 Likert scale on apprehension towards self-injections and 3 Linear Analog Scales on energy, daily activities, and general well-being); compliance (self-report on self-administered injections) and haemoglobin level.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Ten patients were followed for 3 months after intervention. The evolution of the knowledge was positive but not statistically significant after the programme (80% of good answers before; 93% 3 months later). Concerning the patients' skills, difficulties with the pen were important at inclusion, (1) to reset the pen into zero position (2.8 tries/patient +/- 1.8); (2) to insert a new cartridge (1.9 +/- 1.1); and (3) to take air out of the cartridge (2.3 +/- 1.2). After the session, results were satisfactory, since 3 months later, all patients were still on self-injections. QoL improved significantly over the study period respectively on energy, daily activities, and general well-being. The mean level of compliance remained above 90% at 3 months for 8 out of 10 patients. Patients reached the haemoglobin target value of 11 g/dl during the second month of treatment.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>A tailored educational programme conducted by a pharmacist is beneficial for anaemia patients with chronic renal insufficiency. The programme seems to result in a high level of compliance, leading to an optimal haemoglobin level within two months.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17268940</PMID><DateCompleted><Year>2007</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0928-1231</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2007</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pharmacy world & science : PWS</Title><ISOAbbreviation>Pharm World Sci</ISOAbbreviation></Journal><ArticleTitle>Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.</ArticleTitle><Pagination><MedlinePgn>7-11</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Assessment of a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Nephrology Department, Grenoble Hospital, France.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A 12-week prospective study, using a before-after intervention design. Included in the study were predialysis outpatients with a haemoglobin level < 10 g/dl, de novo EPO prescription; judged qualified by the nephrologist for self-injections; accepting self-injections. The intervention was a single one-hour individual session between the pharmacist and the patient to target (1) medical and therapeutic information; (2) information on the device, a pen used with a cartridge of beta epoietin; (3) training with the pen; and (4) self-injection of the first dose by the patient, in front of the pharmacist. Main outcome measures were knowledge (7-item questionnaire); handling skills (observation) and Quality of Life (1 Likert scale on apprehension towards self-injections and 3 Linear Analog Scales on energy, daily activities, and general well-being); compliance (self-report on self-administered injections) and haemoglobin level.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten patients were followed for 3 months after intervention. The evolution of the knowledge was positive but not statistically significant after the programme (80% of good answers before; 93% 3 months later). Concerning the patients' skills, difficulties with the pen were important at inclusion, (1) to reset the pen into zero position (2.8 tries/patient +/- 1.8); (2) to insert a new cartridge (1.9 +/- 1.1); and (3) to take air out of the cartridge (2.3 +/- 1.2). After the session, results were satisfactory, since 3 months later, all patients were still on self-injections. QoL improved significantly over the study period respectively on energy, daily activities, and general well-being. The mean level of compliance remained above 90% at 3 months for 8 out of 10 patients. Patients reached the haemoglobin target value of 11 g/dl during the second month of treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A tailored educational programme conducted by a pharmacist is beneficial for anaemia patients with chronic renal insufficiency. The programme seems to result in a high level of compliance, leading to an optimal haemoglobin level within two months.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allenet</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Département de Pharmacie, Pavillon Moidieu, CHU de Grenoble, BP 217, 38043 Grenoblex 9, France. BAllenet@chu-grenoble.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Romanet</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Vialtel</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Calop</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Pharm World Sci</MedlineTA><NlmUniqueID>9307352</NlmUniqueID><ISSNLinking>0928-1231</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C103998">epoetin beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>11096-26-7</RegistryNumber><NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004921" MajorTopicYN="N">Erythropoietin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006784" MajorTopicYN="N">Hospitals, Teaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007267" MajorTopicYN="N">Injections</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="Y">Patient Compliance</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="Y">Patient Education as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010595" MajorTopicYN="Y">Pharmacists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010607" MajorTopicYN="N">Pharmacy Service, Hospital</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024382" MajorTopicYN="N">Professional Role</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012646" MajorTopicYN="N">Self Administration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>7</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17268940</ArticleId><ArticleId IdType="doi">10.1007/s11096-005-4800-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adv Perit Dial. 2000;16:90-2</Citation><ArticleIdList><ArticleId IdType="pubmed">11045268</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Nephrol. 1995 Nov;44 Suppl 1:S56-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8608665</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2001;16 Suppl 7:20-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11590252</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Health Syst Pharm. 2001 Nov 1;58(21):2061-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11715828</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2002 Sep;40(3):623-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12200815</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2002;17 Suppl 6:8-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12091595</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 1990 Apr;15(4):325-32</Citation><ArticleIdList><ArticleId IdType="pubmed">2321645</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Health Syst Pharm. 2002 Mar 1;59(5):429-35</Citation><ArticleIdList><ArticleId IdType="pubmed">11887409</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2001 Feb;37(2):348-55</Citation><ArticleIdList><ArticleId IdType="pubmed">11157377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 1999;14 Suppl 5:1-50</Citation><ArticleIdList><ArticleId IdType="pubmed">10513295</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2000;15 Suppl 3:23-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11032354</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2001 Feb;16(2):307-12</Citation><ArticleIdList><ArticleId IdType="pubmed">11158405</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mal Vasc. 2004 Jul;29(3):152-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15343110</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2001 Jun 1;19(11):2875-82</Citation><ArticleIdList><ArticleId IdType="pubmed">11387360</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B55 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001B55 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:17268940
|texte= Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:17268940" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |